ImmunityBio Combines Supercomputing Power With Microsoft Azure to Target Infection ?Doorway? of the Coronavirus

EL SEGUNDO, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc., a privately held immunotherapy company within the NantWorks ecosystem of companies, today announced it is collaborating with Microsoft to leverage the company?s Azure platform to perform a highly detailed computational analysis of the spike protein structure of the SARS-CoV-2, the novel coronavirus responsible for the global pandemic. The spike protein serves as the ?doorway? for the virus to enter human cells, making it a high-priority ta

Click to view original post